These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35946350)

  • 1. Antenatal corticosteroids and outcomes into adulthood.
    Doyle LW
    Paediatr Perinat Epidemiol; 2022 Sep; 36(5):640-642. PubMed ID: 35946350
    [No Abstract]   [Full Text] [Related]  

  • 2. Antenatal corticosteroids and longer term outcomes.
    Kimpton J; Sammut A; Cox DJ
    BMJ; 2023 Aug; 382():1722. PubMed ID: 37532272
    [No Abstract]   [Full Text] [Related]  

  • 3. Antenatal corticosteroids to reduce neonatal morbidity and mortality: Green-top Guideline No. 74.
    Stock SJ; Thomson AJ; Papworth S;
    BJOG; 2022 Jul; 129(8):e35-e60. PubMed ID: 35172391
    [No Abstract]   [Full Text] [Related]  

  • 4. The efficacy of antenatal corticosteroids to improve preterm newborn outcomes in low-resource countries: Are we there yet?
    Sultana S; Vogel JP; Oladapo OT
    BJOG; 2023 Nov; 130 Suppl 3():84-91. PubMed ID: 37530472
    [No Abstract]   [Full Text] [Related]  

  • 5. Counterpoint: The value of benchmarking in observational studies of the longer term safety of antenatal corticosteroids.
    Hutcheon JA; Liauw J
    Paediatr Perinat Epidemiol; 2023 Jan; 37(1):15-18. PubMed ID: 36482791
    [No Abstract]   [Full Text] [Related]  

  • 6. The Benefit-Risk Ratio of Late Preterm Antenatal Corticosteroids Could Be Unfavorable in Real-life Situations-Reply.
    Freret TS; Clapp MA
    JAMA Pediatr; 2023 Mar; 177(3):321-322. PubMed ID: 36622670
    [No Abstract]   [Full Text] [Related]  

  • 7. The Benefit-Risk Ratio of Late Preterm Antenatal Corticosteroids Could Be Unfavorable in Real-life Situations.
    Schmitz T; Sénat MV; Sentilhes L
    JAMA Pediatr; 2023 Mar; 177(3):320-321. PubMed ID: 36622655
    [No Abstract]   [Full Text] [Related]  

  • 8. Caution on corticosteroids for preterm delivery: learning from missteps.
    Hodgins S
    Glob Health Sci Pract; 2014 Dec; 2(4):371-3. PubMed ID: 25611469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple courses of antenatal corticosteroids for preterm birth study: 2-year outcomes.
    Asztalos EV; Murphy KE; Hannah ME; Willan AR; Matthews SG; Ohlsson A; Kelly EN; Saigal S; Ross S; Delisle MF; Amankwah K; Guselle P; Gafni A; Lee SK; Armson BA; Sananes R; Tomat L;
    Pediatrics; 2010 Nov; 126(5):e1045-55. PubMed ID: 20956409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal corticosteroids for the late preterm infant and agnotology.
    Kaempf JW; Suresh G
    J Perinatol; 2017 Dec; 37(12):1265-1267. PubMed ID: 29192694
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of antenatal corticosteroids in twin pregnancies complicated by preterm birth.
    Melamed N; Shah J; Yoon EW; Pelausa E; Lee SK; Shah PS; Murphy KE;
    Am J Obstet Gynecol; 2016 Oct; 215(4):482.e1-9. PubMed ID: 27260974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dilemma of antenatal corticosteroids for long-term consequences.
    Yang Y; Li DZ
    Am J Obstet Gynecol; 2023 Jan; 228(1):115-116. PubMed ID: 36041547
    [No Abstract]   [Full Text] [Related]  

  • 13. Controversies in antenatal corticosteroid treatment.
    Thevathasan I; Said JM
    Prenat Diagn; 2020 Aug; 40(9):1138-1149. PubMed ID: 32157719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal corticosteroids administration and threatened preterm birth: could "wait and see" represent the optimal management in selected cases?
    Dall'Asta A; Ghi T
    Am J Obstet Gynecol; 2022 May; 226(5):752-753. PubMed ID: 34896315
    [No Abstract]   [Full Text] [Related]  

  • 15. SMFM Consult Series #58: Need for a clear evidence base to guide expanded use of antenatal corticosteroids for individuals at risk for late preterm delivery.
    Vidaeff AC; Shamshirsaz AA; Aagaard KM
    Am J Obstet Gynecol; 2022 Jun; 226(6):876-877. PubMed ID: 35065017
    [No Abstract]   [Full Text] [Related]  

  • 16. Antenatal Corticosteroids: Who Should We Be Treating?
    Booker WA; Gyamfi-Bannerman C
    Clin Perinatol; 2018 Jun; 45(2):181-198. PubMed ID: 29747882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation.
    Mori R; Kusuda S; Fujimura M;
    J Pediatr; 2011 Jul; 159(1):110-114.e1. PubMed ID: 21334006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal corticosteroids in the late preterm period: A prospective cohort study.
    Ramadan MK; Hussein G; Saheb W; Rajab M; Mirza FG
    J Neonatal Perinatal Med; 2016; 9(1):15-22. PubMed ID: 27002271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory and glycemic control outcomes of late preterm infants after antenatal corticosteroid exposure.
    Janssen O; Ratner V; Lin J; Fox N; Green R
    J Perinatol; 2021 Nov; 41(11):2607-2613. PubMed ID: 34290375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal corticosteroids: Sharpening our aim.
    Vain NE; Althabe F
    Arch Argent Pediatr; 2024 Jun; 122(3):e202310272. PubMed ID: 38154003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.